| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000014924 |
| Receipt No. | R000017353 |
| Official scientific title of the study | A phase II study of laparoscopy assisted total / proximal gastrectomy for gastric cancer |
| Date of disclosure of the study information | 2014/08/22 |
| Last modified on | 2018/07/06 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A phase II study of laparoscopy assisted total / proximal gastrectomy for gastric cancer | |
| Title of the study (Brief title) | A phase II study of laparoscopy assisted total / proximal gastrectomy for gastric cancer | |
| Region |
|
|
| Condition | ||
| Condition | cStage I gastric cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety of laparoscopy assisted total or prioximal gastrectomy (LATG/PG) with nodal dissection for clinical stage IA or IB gastric cancer. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Incidence of anastomotic leakage |
| Key secondary outcomes | proportion of LAG completion, proportion of conversion to open surgery, proportion of anastomotic stenosis, Incidence of anastomotic stenosis, pancreatic fistula or peritoneal abscess, overall survival, recurrence-free survival, adverse events, short-term clinical outcomes
|
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Laparoscopy assisted total and proximal gastrectomy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Histologically proven gastric adenocarcinoma.
2) cStage IA or IB. 3) No indication of endoscopic mucosal resection (EMR) in a cN0 case. 4) Tumor located in the upper 1/3 of the stomach and indication for total or proximal gastrectomy. 5) No invasion to duodenum. 6) Aged 20 to 85 year. 7) Body mass index <30. 8) 13) Written informed consent. |
|||
| Key exclusion criteria | 1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ.
2) Women during pregnancy or breast-feeding. 3) Severe mental disease. 4) Continuous systemic steroid therapy. 5) History of myocardial infarction or unstable angina pectoris within six months. 6) Uncontrollable hypertension. 7) Uncontrollable diabetes millutus. 8) Severe respiratory disease requiring continuous oxygen therapy. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Kazunari Misawa |
| Organization | Aichi Cancer Center Hospital |
| Division name | Department of Gastroenterological Surgery |
| Address | 1-1 Kanokoden Chikuda-ku Nagoya Japan |
| TEL | 0527626111 |
| misawakzn@aichi-cc.jp | |
| Public contact | |
| Name of contact person | Kazunari Misawa |
| Organization | Aichi Cancer Center Hospital |
| Division name | Department of Gastroenterological Surgery |
| Address | 1-1 Kanokoden Chikuda-ku Nagoya Japan |
| TEL | 0527626111 |
| Homepage URL | |
| misawakzn@aichi-cc.jp | |
| Sponsor | |
| Institute | Aichi Cancer Center Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Aichi Cancer Center Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 愛知県がんセンター(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017353 |